| rTMS | repetitive transcranial magnetic stimulation |
| DRE | Drug resistant epilepsy |
| FDA | Food and drug administration |
| MRI | Magnetic resonance imaging |
| ACh | Acetycholine |
| AChE | Acetylcholinesterase |
| ChAT | Choline acetyltransferase |
| CaMK | Calmodulin-dependent kinase |
| CREB | cAMP response element binding |
| CRMP-2 | Collapsin response mediator protein 2 |
| MS | Multiple sclerosis |
| GAD | Generalized anxiety disorder |
| PTSD | Post-traumatic stress disorder |
| BDNF | Brain-derived neurotrophic factor |
| DMEM | Dulbecco Modified Eagle’s Medium |
| EMEM | Eagle’s Minimum Essential Medium |
| DMSO | Dimethylsufloxide |
| FBS | Fetal bovine serum |
| CNS | Central nervous system |
| 4-AP | 4-aminopyridine |
| SLEs | Seizure-like events |
| LTD | Long term depression |
| MEP | Motor evoked potential |
| PD | Pharmacodynamic |
| PK | Pharmacokinetic |